ONVO - Organovo Holdings Stock Price, News & Analysis

$1.51 0.03 (2.03 %)
(As of 11/24/2017 02:39 AM ET)
Previous Close$1.48
Today's Range$1.45 - $1.54
52-Week Range$1.32 - $4.08
Volume655,600 shs
Average Volume1.07 million shs
Market Capitalization$158.25 million
P/E RatioN/A
Dividend YieldN/A
Beta3.13

About Organovo Holdings (NASDAQ:ONVO)

Organovo Holdings logoOrganovo Holdings, Inc. is an early commercial-stage company focused on developing and commercializing functional human tissues. The Company focuses on the generation of three-dimensional (3D) human tissues, by utilizing its platform technology to create human tissue constructs in 3D. It is focused on development of products, including 3D human tissues used for the preclinical assessment of drug effects, including applications in predictive toxicology, absorption, distribution, metabolism, excretion (ADME), and drug metabolism and pharmacokinetics (DMPK); customized human tissues as living, dynamic models of human biology or disease, for use in drug discovery and development, and three-dimensional human tissues for clinical applications, such as blood vessels for bypass grafting, nerve grafts for nerve damage repair and functional tissue patches for the repair or replacement of damaged tissues and organs.


Industry, Sector and Symbol

Industry Biotechnology & Medical Research
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:ONVO
CUSIPN/A

Debt

Debt-to-Equity RatioN/A
Current Ratio12.95%
Quick Ratio12.83%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$4.23 million
Price / Sales38.17
Cash FlowN/A
Price / CashN/A
Book Value$0.49 per share
Price / Book3.08

Dividend

Annual DividendN/A
Dividend YieldN/A

Profitability

Trailing EPS($0.38)
Net Income$-38,440,000.00
Net Margins-923.89%
Return on Equity-65.63%
Return on Assets-60.32%

Miscellaneous

Employees113
Outstanding Shares106,920,000

Frequently Asked Questions for Organovo Holdings (NASDAQ:ONVO)

What is Organovo Holdings' stock symbol?

Organovo Holdings trades on the NASDAQ under the ticker symbol "ONVO."

How were Organovo Holdings' earnings last quarter?

Organovo Holdings, Inc. (NASDAQ:ONVO) issued its quarterly earnings results on Thursday, November, 9th. The medical research company reported ($0.09) EPS for the quarter, topping the Zacks' consensus estimate of ($0.10) by $0.01. The medical research company had revenue of $1.36 million for the quarter, compared to analyst estimates of $1.38 million. Organovo Holdings had a negative net margin of 923.89% and a negative return on equity of 65.63%. The company's revenue was down 1.4% compared to the same quarter last year. View Organovo Holdings' Earnings History.

When will Organovo Holdings make its next earnings announcement?

Organovo Holdings is scheduled to release their next quarterly earnings announcement on Wednesday, February, 7th 2018. View Earnings Estimates for Organovo Holdings.

Where is Organovo Holdings' stock going? Where will Organovo Holdings' stock price be in 2017?

5 analysts have issued 1-year price targets for Organovo Holdings' shares. Their forecasts range from $3.00 to $5.00. On average, they anticipate Organovo Holdings' share price to reach $3.94 in the next twelve months. View Analyst Ratings for Organovo Holdings.

What are Wall Street analysts saying about Organovo Holdings stock?

Here are some recent quotes from research analysts about Organovo Holdings stock:

  • 1. BTIG Research analysts commented, "Reset Delays Ramp; Trimming PT From $5 to $3 We are updating our model and price target to reflect Q3 results and a slower than anticipated revenue ramp as a result of the company’s strategy focus toward fast-growing, higher margin compound screening and disease modeling. We continue to feel ONVO is a long-term investment with sizable market opportunities ($3B+) but as the technology is quite new, predicting the rate at which pharma and research partners will adopt this new technology can be tricky. As our model now incorporates more risk in the near-term given the change in strategy, our revised DCF yields a $3 PT, down from $5 previously. We maintain our Buy rating.   Commentary on revenue mix is encouraging. In the call, management noted a 60%/40% split between repeat and new orders in the first half of the fiscal year, consistent with the mix seen in Fiscal 2017. Additionally, average revenue per order also continues to rise, driven by the aforementioned shift to higher value disease modeling. Finally, management also suggested the potential for a few of its clients to shift from single project to annual revenue commitment contracts over the next couple of quarters.   Valuation: Our price target is $3, based on a DCF analysis that assumes a WACC of 15% and a LT growth rate of 3%. Risks follow on page 6." (11/16/2017)
  • 2. According to Zacks Investment Research, "Organovo Holdings, Inc. is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications. Its NovoGen 3D printing technology is a platform that works across various tissue and cell types. Organovo Holdings, Inc. is based in San Diego, California. " (10/11/2017)

Who are some of Organovo Holdings' key competitors?

Who are Organovo Holdings' key executives?

Organovo Holdings' management team includes the folowing people:

  • Taylor J. Crouch, President, Chief Executive Officer (Age 57)
  • Eric Michael David M.D. J.D., Executive Vice President - Pre-Clinical Development, Chief Strategy Officer (Age 48)
  • Sharon Collins Presnell Ph.D., Chief Scientific Officer (Age 47)
  • Jennifer Kinsbruner Bush J.D., Compliance Officer, General Counsel, Corporate Secretary (Age 41)
  • Paul Gallant, General Manager (Age 51)
  • Richard Maroun, Director
  • Robert F. Baltera Jr., Lead Independent Director (Age 51)
  • James T. Glover, Independent Director (Age 66)
  • Richard A. Heyman Ph.D., Independent Director (Age 59)
  • Tamar D. Howson, Independent Director (Age 68)

Who owns Organovo Holdings stock?

Organovo Holdings' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Essex Investment Management Co. LLC (0.43%) and Granite Investment Partners LLC (0.14%). Company insiders that own Organovo Holdings stock include Eric David and Keith Murphy. View Institutional Ownership Trends for Organovo Holdings.

Who sold Organovo Holdings stock? Who is selling Organovo Holdings stock?

Organovo Holdings' stock was sold by a variety of institutional investors in the last quarter, including Granite Investment Partners LLC. View Insider Buying and Selling for Organovo Holdings.

Who bought Organovo Holdings stock? Who is buying Organovo Holdings stock?

Organovo Holdings' stock was purchased by a variety of institutional investors in the last quarter, including Essex Investment Management Co. LLC. View Insider Buying and Selling for Organovo Holdings.

How do I buy Organovo Holdings stock?

Shares of Organovo Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Organovo Holdings' stock price today?

One share of Organovo Holdings stock can currently be purchased for approximately $1.51.

How big of a company is Organovo Holdings?

Organovo Holdings has a market capitalization of $158.25 million and generates $4.23 million in revenue each year. The medical research company earns $-38,440,000.00 in net income (profit) each year or ($0.38) on an earnings per share basis. Organovo Holdings employs 113 workers across the globe.

How can I contact Organovo Holdings?

Organovo Holdings' mailing address is 6275 NANCY RIDGE DRIVE SUITE 110, SAN DIEGO CA, 92121. The medical research company can be reached via phone at 858-224-1000 or via email at [email protected]


MarketBeat Community Rating for Organovo Holdings (ONVO)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  45 (Vote Outperform)
Underperform Votes:  45 (Vote Underperform)
Total Votes:  90
MarketBeat's community ratings are surveys of what our community members think about Organovo Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Organovo Holdings (NASDAQ:ONVO)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 2 Hold Ratings, 3 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: $3.94 (160.76% upside)

Consensus Price Target History for Organovo Holdings (NASDAQ:ONVO)

Price Target History for Organovo Holdings (NASDAQ:ONVO)

Analysts' Ratings History for Organovo Holdings (NASDAQ:ONVO)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/16/2017BTIG ResearchReiterated RatingBuy$3.00N/AView Rating Details
11/10/2017Citigroup Inc.DowngradeMarket PerformN/AView Rating Details
11/10/2017Raymond James Financial, Inc.DowngradeOutperform -> Market Perform$5.00N/AView Rating Details
9/26/2017Jefferies Group LLCReiterated RatingBuy$4.00HighView Rating Details
6/12/2017Evercore ISILower Price TargetOutperform$4.00 -> $3.75N/AView Rating Details
(Data available from 11/24/2015 forward)

Earnings

Earnings History and Estimates Chart for Organovo Holdings (NASDAQ:ONVO)

Earnings by Quarter for Organovo Holdings (NASDAQ:ONVO)

Earnings History by Quarter for Organovo Holdings (NASDAQ ONVO)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/7/2018N/AView Earnings Details
11/9/2017Q2 2018($0.10)($0.09)$1.38 million$1.36 millionViewN/AView Earnings Details
8/9/2017Q1 2018($0.10)($0.10)$0.92 million$0.99 millionViewListenView Earnings Details
6/7/2017Q4 2017($0.11)($0.10)$0.76 million$0.80 millionViewListenView Earnings Details
2/9/2017Q3 2017($0.10)($0.09)$1.40 million$1.15 millionViewListenView Earnings Details
11/3/2016Q217($0.11)($0.10)$0.50 million$1.38 millionViewListenView Earnings Details
8/4/2016Q1($0.10)($0.09)$0.30 million$0.89 millionViewListenView Earnings Details
6/9/2016Q4($0.11)($0.09)$0.10 million$0.55 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Organovo Holdings (NASDAQ:ONVO)
2018 EPS Consensus Estimate: ($0.10)
2019 EPS Consensus Estimate: ($0.32)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20181($0.10)($0.10)($0.10)
Q1 20191($0.09)($0.09)($0.09)
Q2 20191($0.09)($0.09)($0.09)
Q3 20191($0.07)($0.07)($0.07)
Q4 20191($0.07)($0.07)($0.07)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Organovo Holdings (NASDAQ:ONVO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Organovo Holdings (NASDAQ ONVO)

Insider Ownership Percentage: 10.20%
Institutional Ownership Percentage: 26.84%
Insider Trades by Quarter for Organovo Holdings (NASDAQ:ONVO)
Institutional Ownership by Quarter for Organovo Holdings (NASDAQ:ONVO)

Insider Trades by Quarter for Organovo Holdings (NASDAQ ONVO)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/9/2017Keith MurphyCEOSell25,000$3.68$92,000.00View SEC Filing  
1/24/2017Keith MurphyCEOSell25,000$3.51$87,750.00View SEC Filing  
12/14/2016Keith MurphyCEOSell50,000$3.72$186,000.00View SEC Filing  
8/5/2016Eric DavidEVPSell20,000$4.55$91,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Organovo Holdings (NASDAQ ONVO)

Source:
DateHeadline
Zacks: Organovo Holdings, Inc. (ONVO) Receives Average Recommendation of "Buy" from BrokeragesZacks: Organovo Holdings, Inc. (ONVO) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - November 19 at 1:16 PM
Organovo Holdings, Inc. (ONVO) Given "Buy" Rating at BTIG ResearchOrganovo Holdings, Inc. (ONVO) Given "Buy" Rating at BTIG Research
www.americanbankingnews.com - November 16 at 10:40 AM
Contrasting Organovo Holdings (ONVO) & Novelion Therapeutics (NVLN)Contrasting Organovo Holdings (ONVO) & Novelion Therapeutics (NVLN)
www.americanbankingnews.com - November 16 at 8:37 AM
 Organovo Holdings, Inc. (ONVO) Given $3.25 Consensus Target Price by Brokerages Organovo Holdings, Inc. (ONVO) Given $3.25 Consensus Target Price by Brokerages
www.americanbankingnews.com - November 15 at 5:06 AM
Zacks: Analysts Expect Organovo Holdings, Inc. (ONVO) Will Announce Quarterly Sales of $1.93 MillionZacks: Analysts Expect Organovo Holdings, Inc. (ONVO) Will Announce Quarterly Sales of $1.93 Million
www.americanbankingnews.com - November 14 at 6:04 AM
Organovo Holdings, Inc. (ONVO) Expected to Post Earnings of -$0.09 Per ShareOrganovo Holdings, Inc. (ONVO) Expected to Post Earnings of -$0.09 Per Share
www.americanbankingnews.com - November 12 at 5:42 PM
Organovo Holdings, Inc. (ONVO) Rating Lowered to Market Perform at Raymond James Financial, Inc.Organovo Holdings, Inc. (ONVO) Rating Lowered to Market Perform at Raymond James Financial, Inc.
www.americanbankingnews.com - November 12 at 11:16 AM
Citigroup Inc. Downgrades Organovo Holdings, Inc. (ONVO) to Market PerformCitigroup Inc. Downgrades Organovo Holdings, Inc. (ONVO) to Market Perform
www.americanbankingnews.com - November 10 at 2:48 PM
Organovo Holdings, Inc. (ONVO) Releases  Earnings Results, Beats Estimates By $0.01 EPSOrganovo Holdings, Inc. (ONVO) Releases Earnings Results, Beats Estimates By $0.01 EPS
www.americanbankingnews.com - November 9 at 10:36 PM
Head-To-Head Comparison: Organovo Holdings (ONVO) and The CompetitionHead-To-Head Comparison: Organovo Holdings (ONVO) and The Competition
www.americanbankingnews.com - November 6 at 1:20 AM
Organovo Holdings (ONVO) vs. Its Rivals Head to Head ReviewOrganovo Holdings (ONVO) vs. Its Rivals Head to Head Review
www.americanbankingnews.com - November 5 at 1:20 PM
Organovo Holdings, Inc. (ONVO) Receives Consensus Recommendation of "Hold" from AnalystsOrganovo Holdings, Inc. (ONVO) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - November 2 at 12:00 PM
Organovo Holdings, Inc. (ONVO) Set to Announce Earnings on ThursdayOrganovo Holdings, Inc. (ONVO) Set to Announce Earnings on Thursday
www.americanbankingnews.com - November 2 at 3:04 AM
ETFs with exposure to Organovo Holdings, Inc. : October 30, 2017ETFs with exposure to Organovo Holdings, Inc. : October 30, 2017
finance.yahoo.com - October 31 at 7:29 AM
Organovo (ONVO) Reports New Preclinical Data on 3D Bioprinted ... - StreetInsider.comOrganovo (ONVO) Reports New Preclinical Data on 3D Bioprinted ... - StreetInsider.com
www.streetinsider.com - October 21 at 7:29 AM
Organovo Presents New Preclinical Data on 3D Bioprinted Human Liver Tissues for the Treatment of Inborn Errors of Metabolism at The Liver Meeting® 2017 (AASLD)Organovo Presents New Preclinical Data on 3D Bioprinted Human Liver Tissues for the Treatment of Inborn Errors of Metabolism at The Liver Meeting® 2017 (AASLD)
finance.yahoo.com - October 21 at 7:29 AM
ETFs with exposure to Organovo Holdings, Inc. : October 20, 2017ETFs with exposure to Organovo Holdings, Inc. : October 20, 2017
finance.yahoo.com - October 21 at 7:29 AM
Organovo Announces Release Date for Fiscal Second-Quarter 2018 Financial ResultsOrganovo Announces Release Date for Fiscal Second-Quarter 2018 Financial Results
finance.yahoo.com - October 20 at 7:08 AM
Organovo Holdings, Inc. (ONVO) Stock Rating Upgraded by Zacks Investment ResearchOrganovo Holdings, Inc. (ONVO) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - October 15 at 11:32 PM
Critical Review: Organovo Holdings (ONVO) & Its RivalsCritical Review: Organovo Holdings (ONVO) & Its Rivals
www.americanbankingnews.com - October 13 at 2:20 PM
ETFs with exposure to Organovo Holdings, Inc. : October 9, 2017ETFs with exposure to Organovo Holdings, Inc. : October 9, 2017
finance.yahoo.com - October 9 at 8:48 PM
Q3 2018 EPS Estimates for Organovo Holdings, Inc. Decreased by Analyst (ONVO)Q3 2018 EPS Estimates for Organovo Holdings, Inc. Decreased by Analyst (ONVO)
www.americanbankingnews.com - October 9 at 5:56 AM
Organovo Holdings, Inc. (ONVO) Given Average Rating of "Hold" by BrokeragesOrganovo Holdings, Inc. (ONVO) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - October 8 at 9:00 AM
Organovo Holdings, Inc. :ONVO-US: Earnings Analysis: Q1, 2018 By the Numbers : October 6, 2017Organovo Holdings, Inc. :ONVO-US: Earnings Analysis: Q1, 2018 By the Numbers : October 6, 2017
finance.yahoo.com - October 6 at 9:11 AM
Organovo to cut 13% of workforce, announces preliminary revenues - Seeking AlphaOrganovo to cut 13% of workforce, announces preliminary revenues - Seeking Alpha
seekingalpha.com - October 5 at 1:56 PM
Organovo Holdings, Inc. (ONVO) Receives "Buy" Rating from Jefferies Group LLCOrganovo Holdings, Inc. (ONVO) Receives "Buy" Rating from Jefferies Group LLC
www.americanbankingnews.com - September 26 at 8:56 PM
The Competitive Case For Organovo Holdings - Seeking AlphaThe Competitive Case For Organovo Holdings - Seeking Alpha
seekingalpha.com - September 22 at 7:31 AM
Jefferies Group LLC Reiterates "Buy" Rating for Organovo Holdings, Inc. (ONVO)Jefferies Group LLC Reiterates "Buy" Rating for Organovo Holdings, Inc. (ONVO)
www.americanbankingnews.com - September 14 at 7:16 PM
Organovo Holdings, Inc. (ONVO) Given Average Recommendation of "Hold" by AnalystsOrganovo Holdings, Inc. (ONVO) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - September 13 at 9:34 AM
BRIEF-Organovo says Keith Murphy submitted resignation as chairman of board‍BRIEF-Organovo says Keith Murphy submitted resignation as chairman of board‍
www.reuters.com - August 29 at 6:23 AM
Global 3D Bioprinting Market Outlook to 2022 - Focus on Technology, Application and Materials - Research and MarketsGlobal 3D Bioprinting Market Outlook to 2022 - Focus on Technology, Application and Materials - Research and Markets
www.businesswire.com - August 26 at 8:01 AM
Organovo Sponsors Pioneering Research With Amgen and Medikine in Critical Areas of Liver and Kidney Disease - NasdaqOrganovo Sponsors Pioneering Research With Amgen and Medikine in Critical Areas of Liver and Kidney Disease - Nasdaq
www.nasdaq.com - August 23 at 9:49 AM
Organovo Sponsors Pioneering Research With Amgen and Medikine in Critical Areas of Liver and Kidney DiseaseOrganovo Sponsors Pioneering Research With Amgen and Medikine in Critical Areas of Liver and Kidney Disease
finance.yahoo.com - August 23 at 9:49 AM
Organovo Holdings, Inc. (ONVO) Receives Consensus Rating of "Buy" from AnalystsOrganovo Holdings, Inc. (ONVO) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - August 19 at 9:02 AM
Q3 2018 Earnings Forecast for Organovo Holdings, Inc. (NASDAQ:ONVO) Issued By Jefferies GroupQ3 2018 Earnings Forecast for Organovo Holdings, Inc. (NASDAQ:ONVO) Issued By Jefferies Group
www.americanbankingnews.com - August 14 at 7:54 AM
ETFs with exposure to Organovo Holdings, Inc. : August 11, 2017ETFs with exposure to Organovo Holdings, Inc. : August 11, 2017
finance.yahoo.com - August 12 at 6:36 AM
Organovo Holdings, Inc. (ONVO) Announces  Earnings Results, Hits EstimatesOrganovo Holdings, Inc. (ONVO) Announces Earnings Results, Hits Estimates
www.americanbankingnews.com - August 11 at 9:58 PM
Organovo Holdings Revenue Is Growing at a Snail's Pace Compared With Prior QuartersOrganovo Holdings Revenue Is Growing at a Snail's Pace Compared With Prior Quarters
finance.yahoo.com - August 11 at 7:16 AM
Investor Network: Organovo Holdings, Inc. to Host Earnings CallInvestor Network: Organovo Holdings, Inc. to Host Earnings Call
finance.yahoo.com - August 10 at 6:29 AM
Organovo Announces Fiscal First-Quarter 2018 Results; Company Affirms Full-Year Fiscal 2018 OutlookOrganovo Announces Fiscal First-Quarter 2018 Results; Company Affirms Full-Year Fiscal 2018 Outlook
finance.yahoo.com - August 10 at 6:29 AM
Edited Transcript of ONVO earnings conference call or presentation 9-Aug-17 9:00pm GMTEdited Transcript of ONVO earnings conference call or presentation 9-Aug-17 9:00pm GMT
finance.yahoo.com - August 10 at 6:29 AM
Organovo reports 1Q lossOrganovo reports 1Q loss
finance.yahoo.com - August 10 at 6:29 AM
Organovo (ONVO) Secures 3-Yr $1.7M Grants from National Institutes of Health to Study Liver DiseaseOrganovo (ONVO) Secures 3-Yr $1.7M Grants from National Institutes of Health to Study Liver Disease
www.streetinsider.com - August 1 at 5:34 AM
Organovo (ONVO) Secures 3-Yr $1.7M Grants from National Institutes of Health to Study Liver Disease - StreetInsider.comOrganovo (ONVO) Secures 3-Yr $1.7M Grants from National Institutes of Health to Study Liver Disease - StreetInsider.com
www.streetinsider.com - August 1 at 12:31 AM
Organovo and UC San Diego Receive $1.7 Million Grant From National Institutes of Health to Study Liver DiseaseOrganovo and UC San Diego Receive $1.7 Million Grant From National Institutes of Health to Study Liver Disease
finance.yahoo.com - August 1 at 12:31 AM
ETFs with exposure to Organovo Holdings, Inc. : July 31, 2017ETFs with exposure to Organovo Holdings, Inc. : July 31, 2017
finance.yahoo.com - August 1 at 12:31 AM
Organovo Holdings, Inc. (ONVO) Short Interest Down 7.2% in JulyOrganovo Holdings, Inc. (ONVO) Short Interest Down 7.2% in July
www.americanbankingnews.com - July 28 at 1:24 AM
Organovo Holdings, Inc. (NASDAQ:ONVO) Rating Reiterated by Jefferies Group LLCOrganovo Holdings, Inc. (NASDAQ:ONVO) Rating Reiterated by Jefferies Group LLC
www.americanbankingnews.com - July 27 at 5:55 PM
$880,000.00 in Sales Expected for Organovo Holdings, Inc. (NASDAQ:ONVO) This Quarter$880,000.00 in Sales Expected for Organovo Holdings, Inc. (NASDAQ:ONVO) This Quarter
www.americanbankingnews.com - July 20 at 11:44 AM
Organovo Announces Release Date for Fiscal First-Quarter 2018 Financial ResultsOrganovo Announces Release Date for Fiscal First-Quarter 2018 Financial Results
finance.yahoo.com - July 19 at 12:55 AM

Social Media

Financials

Chart

Organovo Holdings (NASDAQ ONVO) Chart for Friday, November, 24, 2017
Loading chart…

This page was last updated on 11/24/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.